PubMed HealthSearch

PubMed · 6171792

The malfunctioning pacemaker system. Part I.

Abstract

The success of an implanted cardiac pacemaker is dependent upon the establishment of a harmonious relationship between the artificial pacemaker and the human receiver. Failure of a pacemaker system may arise from an electronic or mechanical defect within the pacemaker, a physiologic problem, or from a poor relationship between the normal function of both. Such malfunctions may necessitate the repair, replacement, or repositioning of a pacemaker component or removal of a source of external interference. True pacemaker malfunctions must be clearly distinguished from pseudo-malfunctions, where there is no pacemaker system defect. These situations may, variously, require the repair of faulty testing equipment, reassessment of falsely interpreted test data, or treatment of the patient for an unrelated disorder. This paper outlines a system for investigating patients with suspected pacemaker malfunction. For simplicity, only malfunctions associated with the ventricular inhibited pacing system will be discussed.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H G Mond, J G Sloman. 1981. The malfunctioning pacemaker system. Part I.. https://doi.org/10.1111/j.1540-8159.1981.tb03674.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Clinical trials of pacing mode selection.

Current recommendations in favor of dual-chamber over single-chamber ventricular pacing for patients with sinus node dysfunction or AV conduction disorders were made largely based on observational data and expert opinions. The first randomized pacing mode selection study was relatively small and suggested survival advantage with physiologic pacing only after an extended follow-up duration of 5.5 years. Preliminary results of the first large-scale multicenter randomized pacing mode selection trial revealed only modest reduction in atrial fibrillation without survival advantage after 3 years of physiologic pacing. Two other large-scale multicenter randomized trials comparing physiologic versus ventricular pacing are currently ongoing. They may provide further scientific evidence based on which more objective recommendations can be made with respect to pacing mode selection.

Cardiac Pacing, Artificial

Pacing in hypertrophic cardiomyopathy.

Dual chamber pacing has been proposed as an alternative to surgery in the management of hypertrophic cardiomyopathy. Reports have documented hemodynamic and symptomatic benefit from dual chamber pacing, raising the question of whether or not all patients with drug-refractory symptoms should undergo a trial of pacing before consideration of surgery. The enthusiasm for pacing in hypertrophic cardiomyopathy has generated a number of investigations addressing this issue, including several recently concluded clinical trials. This article reviews the recent experience with dual chamber pacing in hypertrophic cardiomyopathy.

Cardiac Pacing, Artificial

Developing clinical indication for multisite pacing.

The artificial activation of the heart modifies the mechanics of contraction and relaxation. While only little basic research has been addressed to this question, clinical observations showed that for hypertrophic as well as dilated cardiomyopathies appropriate pacing techniques can be useful. Pacing can influence the activation sequence. The spread out from a single site is slow, and so hypercontractility deminshed. With the use of multiple electrodes, two atrial and/or two ventricular, conduction delays in the atria or ventricles can be eliminated. Synchronisation of the cardiac activation has an anti-arrhythmic and positiv inotropic effect. This may lead to new indications for pacemakers or better to be named cardiac synchronisers.

Cardiac Pacing, Artificial